Dr. In-Kyu Yoon Appointed as Director of the Dengue Vaccine Initiative
July 24, 2015 –The International Vaccine Institute (IVI) is pleased to announce the arrival of Dr. In-Kyu Yoon as Director of the Dengue Vaccine Initiative (DVI). Dr. Yoon, former Chief of the Department of Virology, Armed Forces Research Institute Medical Sciences in Bangkok, Thailand, will lead DVI from August, 2015.
“We greatly look forward to Dr. Yoon’s leadership of DVI,” said Dr. Jerome Kim, IVI Director General, “Dr. Yoon’s extensive research experience and knowledge of dengue and vaccine clinical trials will further strengthen DVI’s management and operations. His experience will be welcomed by IVI as he can also provide additional scientific leadership at the Institute."
In his previous position, Dr. Yoon investigated arbovirus and respiratory virus infections including clinical trials of candidate vaccines. He has conducted research on the epidemiology, pathophysiology and immunology of dengue virus and other emerging pathogens, and has authored over 70 publications.
He has provided clinical care in a variety of civilian and military settings internationally, and served as a faculty member of the Uniformed Services University of the Health Sciences in Maryland, United States. Dr. Yoon graduated magna cum laude with a BS degree from Yale University in 1988 and received his MD from the New York University School of Medicine in 1993. He completed residency training in Internal Medicine and fellowship training in Allergy/Immunology at the Walter Reed Army Medical Center.
DVI is run as an international consortium led by IVI in collaboration with the Sabin Vaccine Institute, Johns Hopkins University, and World Health Organization to support the development and introduction of vaccines to control dengue fever, a widespread and expanding hemorrhagic fever that is endemic in most tropical and subtropical regions of the world. The Initiative is supported by the Bill & Melinda Gates Foundation (BMGF)